Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 26 (3), 163-70

Use of Antioxidants to Prevent Cyclosporine a Toxicity

Affiliations
Review

Use of Antioxidants to Prevent Cyclosporine a Toxicity

Jinhwa Lee. Toxicol Res.

Abstract

Cyclosporine A (CsA) is a potent immunosuppressor that is widely used in transplant surgery and the treatment of several autoimmune diseases. However, major side effects of CsA such as nephrotoxicity, hepatotoxicity, neurotoxicity and cardiovascular diseases have substantially limited its usage. Although molecular mechanisms underlying these adverse effects are not clearly understood, there is some evidence that suggests involvement of reactive oxygen species (ROS) . In parallel, protective effects of various antioxidants have been demonstrated by many research groups. Extensive studies of CsA-induced nephrotoxcity have confirmed that the antioxidants can restore the damaged function and structure of kidney. Subsequently, there have appeared numerous reports to demonstrate the positive antioxidant effects on liver and other organ damages by CsA. It may be timely to review the ideas to envisage the relationship between ROS and the CsA-induced toxicity. This review is comprised of a brief description of the immunosuppressive action and the secondary effects of CsA, and a synopsis of reports regarding the antioxidant treatments against the ROS-linked CsA toxicity. A plethora of recent reports suggest that antioxidants can help reduce many CsA's adverse effects and therefore might help develop more effective CsA treatment regimens.

Keywords: Antioxidant; Cylcosporine A; Immunosuppressant; ROS; Toxicity.

Similar articles

See all similar articles

Cited by 9 PubMed Central articles

See all "Cited by" articles

References

    1. Al-Malki A.L. Moselhy S.S. The protective effect of epicatchin against oxidative stress and nephrotoxicity in rats induced by cyclosporine. Hum. Exp. Toxicol. 2011;30:145–151. - PubMed
    1. Amudha G. Josephine A. Sudhahar V. Varalakshmi P. Protective effect of lipoic acid on oxidative and peroxidative damage in cyclosporine A-induced renal toxicity. Int. Immunopharmacol. 2007;7:1442–1449. doi: 10.1016/j.intimp.2007.06.010. - DOI - PubMed
    1. Arnadottir M. Hultberg B. Vladov V. Nilsson-Ehle P. Thysell H. Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients. Transplantation. 1996;61:509–512. doi: 10.1097/00007890-199602150-00034. - DOI - PubMed
    1. Baid S. Cosimi A.B. Farrell M.L. Schoenfeld D.A. Feng S. Chung R.T. Tolkoff-Rubin N. Pascual M. Post-transplant diabetes mellitus in liver transplant recipients: risk factors temporal relationship with hepatitis C virus allograft hepatitis and impact on mortality. Transplantation. 2001;72:1066–1072. doi: 10.1097/00007890-200109270-00015. - DOI - PubMed
    1. Beckman J.A. Creager M.A. Libby P. Diabetes and atherosclerosis: epidemiology pathophysiology and management. JAMA. 2002;287:2570–2581. doi: 10.1001/jama.287.19.2570. - DOI - PubMed

LinkOut - more resources

Feedback